Komori
T.O. Holdings (9812) · InitiativeAchieved

Company Split of the Care Services Business and Other Operations and Transfer of All Shares in 廣辯株式会社

First written in FY2021-Q3. 1 of 1 entries say "Achieved", first in FY2021-Q3. Latest entry: FY2021-Q3.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Removal from the Scope of Consolidation Through the Transfer of Shares in a SubsidiaryA theme 314 companies write about · 44 as a headwind · 223 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 156 companies compared. The sentences above are computed from all 156.Comparing 200 of the theme's 397 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2021-Q3AchievedAnnual report

    「At a meeting of the Board of Directors held on 12 February 2021, the Company resolved to establish its wholly owned subsidiary 廣辯株式会社 on 15 February 2021 and to enter into absorption-type company split agreements, with 1 April 2021 as the effective date, to transfer to 廣辯 the care-services business operated by the Company's wholly owned subsidiary 株式会社テーオー総合サービス (the business includes the operation and management of housing for seniors with support services and various services under the Long-Term Care Insurance Act) and part of the real-estate leasing business operated by the Company (the leasing of real estate used for TOSS's care-services business). The split by TOSS was designated as “Company Split ①” and the split by the Company as “Company Split ②,” collectively referred to as the “Company Split.” Subject to the effectiveness of the Company Split, the Company also resolved to transfer all shares in 廣辯 to アサヒ調剤薬局株式会社 on 1 April 2021. The absorption-type company split and the transfer of all shares in 廣辯 were completed on 1 April 2021.」

    The Company disclosed a transaction in which the care-services business and part of the real-estate leasing business used for that business were transferred to the newly established wholly owned subsidiary 廣辯, followed by the transfer of all shares in 廣辯 to アサヒ調剤薬局株式会社. The company split and share transfer were completed on 1 April 2021, representing a concrete portfolio reorganization in which a business with limited expected synergies with the core businesses was transferred to a locally focused buyer.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
T.O. Holdings's next results are scheduled for 2026-10-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.